BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36724931)

  • 1. [Survey of Prophylactic Administration of Naldemedine for Opioid-induced Constipation].
    Ozawa Y; Haruki Y; Ohata M; Isono H; Takahashi M; Tate A; Ukita S; Hayashi S
    Yakugaku Zasshi; 2023; 143(2):183-189. PubMed ID: 36724931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Predictive Factors for Diarrhea after the Administration of Naldemedine.
    Hashizume J; Shiojiri K; Ryu E; Kawauchi Y; Hasegawa K; Ezaki N; Yamashita H; Ishii K; Harasawa H; Nakamura T; Sasaki H; Kodama Y
    Biol Pharm Bull; 2021; 44(8):1081-1087. PubMed ID: 34334493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status.
    Fujita Y; Imai H; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Sandoh M; Takei S; Arai K; Nishiba H; Mogi J; Koizuka S; Saito T; Obayashi K; Kaira K; Minato K
    J Palliat Med; 2023 Apr; 26(4):548-553. PubMed ID: 36971576
    [No Abstract]   [Full Text] [Related]  

  • 4. A Retrospective Observational Study of Factors Affecting the Efficacy of Concurrent Prescription of Naldemedine for Opioid-Induced Constipation Caused by Oxycodone Tablets.
    Yamada M; Jimaru Y; Torii S; Mitsuba N; Takahashi K
    Biol Pharm Bull; 2023; 46(12):1826-1831. PubMed ID: 38044102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.
    Kanbayashi Y; Shimizu M; Ishizuka Y; Sawa S; Yabe K; Uchida M
    PLoS One; 2022; 17(12):e0278823. PubMed ID: 36490241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
    Kamiya T; Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Sandoh M; Takei S; Arai K; Nishiba H; Mogi J; Koizuka S; Saito T; Obayashi K; Kaira K; Minato K
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984494
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis.
    Nishiba H; Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Ito M; Takei S; Matsuura M; Mogi J; Obayashi K; Minato K
    Ann Palliat Med; 2023 Jul; 12(4):697-707. PubMed ID: 37081703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and management of diarrhea associated with naldemedine among patients receiving opioids: a retrospective cohort study.
    Takagi Y; Osawa G; Kato Y; Ikezawa E; Kobayashi C; Aruga E
    BMC Gastroenterol; 2020 Jan; 20(1):25. PubMed ID: 32005157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer.
    Katakami N; Oda K; Tauchi K; Nakata K; Shinozaki K; Yokota T; Suzuki Y; Narabayashi M; Boku N
    J Clin Oncol; 2017 Jun; 35(17):1921-1928. PubMed ID: 28445097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-induced constipation.
    Wein S
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):382-4. PubMed ID: 23216186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
    Hale M; Wild J; Reddy J; Yamada T; Arjona Ferreira JC
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):555-564. PubMed ID: 28576452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-Related Constipation.
    Liu JJ; Brenner DM
    Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the use of pharmacotherapy for opioid-induced bowel dysfunction.
    Mousavi T; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2023 Feb; 24(3):359-375. PubMed ID: 36548911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan.
    Takata K; Nakazawa M; Honda K; Hashimoto S
    Support Care Cancer; 2022 May; 30(5):3943-3954. PubMed ID: 35044484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of the efficacy and safety of naldemedine for opioid-induced constipation in thoracic cancer patients.
    Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Sandoh M; Takei S; Arai K; Nishiba H; Mogi J; Kaira K; Minato K
    Thorac Cancer; 2022 Aug; 13(16):2301-2308. PubMed ID: 35790500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of naldemedine for the treatment of opioid-induced constipation.
    Song X; Wang D; Qu X; Dong N; Teng S
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):121-128. PubMed ID: 30652502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripherally-active mu-opioid receptor antagonists for constipation in critically ill patients receiving opioids: A case-series and a systematic review and meta-analysis of the literature.
    Umbrello M; Venco R; Palandri C; Racagni M; Muttini S
    Neurogastroenterol Motil; 2023 Dec; 35(12):e14694. PubMed ID: 37869768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.